Patents
US 12617838 B2: Auto/allo-immune defense receptors for the selective targeting of activated pathogenic T cells and NK cells
- Granted
- 2026-05-05
- Filed
- 2019-04-25 application 17049561
- Type
- Utility · 24 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Embodiments of the disclosure concern engineered auto/allo-immune defense receptor (ADR)-expressing T cells that selectively target activated T cells, including pathogenic T cells, to incapacitate them. The chimeric receptors comprise moieties for targeting 4-1BB, 0X40, and CD40L, for example, whose expression is indicative of activated T cells. In particular embodiments, there are methods of preventing or treating conditions associated with activated T cells using adoptive T-cell transfer of cells encoding the ADRs.
Source: PTBLXML, file of 2026-05-05 (ipgb20260505.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Baylor College of Medicine 276 patents | US company or organization | Houston, TX | Baylor College of Medicine College or university EXACT high confidence: identical full name and state BAYLOR COLLEGE OF MEDICINE Nonprofit EXACT high confidence: identical full name and state | PTBLXML, file of 2026-05-05 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Maksim Mamonkin | Houston, TX | 3 | PTBLXML, file of 2026-05-05 | |
| Malcolm K. Brenner | Houston, TX | 14 | PTBLXML, file of 2026-05-05 | |
| Feiyan Mo | Houston, TX | PTBLXML, file of 2026-05-05 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C07K | Peptides | C07K14/70578 | PTBLXML, file of 2026-05-05 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K40/11 | PTBLXML, file of 2026-05-05 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P37/06 | PTBLXML, file of 2026-05-05 |
| C12N | Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media | C12N5/0636 | PTBLXML, file of 2026-05-05 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2020-10-21 | Assignment Assignment of assignor's interest | MAMONKIN, MAKSIM signed 2019-05-02 BRENNER, MALCOLM K. signed 2019-07-28 MO, FEIYAN signed 2019-05-03 | BAYLOR COLLEGE OF MEDICINE HOUSTON, TX | 54132/19 | PASDL, file of 2026-10-15 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.